RXST FY2025 SEC EDGAR DEF 14A #77 of 86 in industry

RxSight, Inc. CEO pay ratio

The CEO earned $4.6M in FY2025 against median worker pay of $164,848 · Measuring Instruments.

Measuring Instruments peers All rankings
State
DE
Filing date
2026-04-28
Industry
Measuring Instruments
Industry rank
#77/86

Data updated August 2026

Subscribe to RxSight, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
28:1
Below Average (Scale: 0–1000:1)
CEO pay
$4.6M
Median worker
$164,848

Answer first

RxSight, Inc.'s FY2025 CEO total of $4.6M ranks #958 of 1,423 complete filings; its 28:1 pay ratio ranks #1148. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $164,848. Industry placement uses the FY2025 SIC-38 peer cohort (# 77 of 86, 12th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.

Dollar rank
#958
$4.6M of 1,423 FY2025
Ratio rank
#1148
28:1 of 1,423
Industry pct
12th
among the lower quartile of industry peers by pay ratio

How RxSight, Inc. ranks nationally

RxSight, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$4,615,744 33rd percentile higher than 33% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

RxSight, Inc. vs. Measuring Instruments peers

CEO total pay ($4.6M) against pay ratio (28:1) for RxSight, Inc. (marked) and its 5 closest same-industry peers, against the Measuring Instruments industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02105664.54211328.96316993.48422657.917.1:144.2:171.3:198.3:1125.4:1CEO total payPay ratio (CEO : median worker)RxSight, Inc., CEO total pay: 4615744 · Pay ratio (CEO : median worker): 28:1RxSight, Inc.Outset Medical, Inc., CEO total pay: 135629 · Pay ratio (CEO : median worker): 24:1Outset Medical, Inc.10x Genomics, Inc., CEO total pay: 6329244 · Pay ratio (CEO : median worker): 32:110x Genomics, Inc.Pacific Biosciences Of California, Inc., CEO total pay: 4309846 · Pay ratio (CEO : median worker): 22:1Pacific Biosciences Of California, Inc.Globus Medical Inc, CEO total pay: 128616 · Pay ratio (CEO : median worker): 35:1Globus Medical IncInspire Medical Systems, Inc., CEO total pay: 7711784 · Pay ratio (CEO : median worker): 35:1Inspire Medical Systems, Inc.
RxSight, Inc. vs. Measuring Instruments peers, plotted against the industry's $8.0M median CEO total and 121:1 median pay ratio.

Ratio bands among Measuring Instruments peers

Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in RxSight, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · RxSight, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
28:1
FY2025
vs prior FY
-19:1
from FY2024 47:1
CEO $ YoY
-34%
$4.6M latest
Filings shown
2
FY2024–2025
RxSight, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $7.0M - $148,932 47:1 -
2025 $4.6M -34% $164,848 28:1 -19:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1111485, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Measuring Instruments

This Company's Ratio
28:1
Industry Median Ratio
121:1
Industry Median CEO Pay
$8.0M
This CEO's Pay
$4.6M
Companies in Industry
86
vs. Industry Median
Below
#77 of 86 by pay ratio in this industry View all companies in Measuring Instruments →

RxSight, Inc.: MODEST · MID$ pay ratio

RxSight, Inc.'s FY2025 ratio 28:1 ranks #77 of 86 Measuring Instruments filers (12th percentile). the CEO earned 28× the median employee ($164,848) in FY2025.

Median employee $164,848 (ELITE-MED); MODEST · MID$ stamps put about 28 median-wage years per CEO year.

CEO Total Pay

$4.6M

FY2025 Summary Compensation, below median

Pay Ratio

28:1

Below typical

RxSight, Inc. in the lower Measuring Instruments third

RxSight, Inc.'s FY2025 ratio 28:1 ranks #77 of 86 Measuring Instruments filers (12th percentile). The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; RxSight, Inc.'s $4.6M CEO total is at or below the $8.0M industry median CEO pay.

Dollar rank #958 and ratio rank #1148 split - treat 28:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.

Key Data, FY2025

Total Compensation
$4.6M
Median Employee Pay
$164,848
Pay Ratio
28:1
Filing Date
2026-04-28

Company Info

Ticker
RXST
CIK
1111485
Industry
Measuring Instruments
SIC Code
3851
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1111485, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. RxSight, Inc.'s FY2025 ratio 28:1 ranks #77 of 86 Measuring Instruments filers (12th percentile).

Read with RxSight, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · ELITE-MED.

TrueBlue, Inc. · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $4K lighter vs RxSight, Inc.); HIGH · LOW-MED vs this page's MODEST · MID$ · ELITE-MED.
Triumph Financial, Inc. · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $8K lighter vs RxSight, Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · ELITE-MED.
First Interstate Bancsystem Inc · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $9K lighter vs RxSight, Inc.); MID · PAR-MED vs this page's MODEST · MID$ · ELITE-MED.
Wendy's Co · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $12K heavier vs RxSight, Inc.); STEEP · LOW-MED vs this page's MODEST · MID$ · ELITE-MED.
Outset Medical, Inc. (SIC 38 pole)

Outset Medical, Inc. stamps FLOOR · MICRO nearest in-SIC by ABS(pay_ratio) to RxSight, Inc.'s MODEST filing.
National dual ranks · #958/#1148

RxSight, Inc.'s FY2025 package sits #958 by CEO dollars and #1148 by ratio under MID$ · MODEST.
Ratio primer · MODEST

RxSight, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for RxSight, Inc. (CIK 1111485), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.